A clinical trial of the anti-malaria drug hydroxychloroquine in coronavirus patients has been suspended amid safety concerns.
The drug has been touted by President Donald Trump and he even revealed he took the medication for two weeks as a prophylactic.
But the World Health Organization (WHO) said it was concerned after a study from The Lancet published on Friday revealed higher mortality rates among COVID-19 patients who took the drug.
Therefore, researchers said they’re suspending the use of hydroxychloroquine in the WHO’s Solidarity Trial, which is to evaluate the safety and efficacy of four drugs and drug combinations against the virus.
‘The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,’ WHO Director-General Tedros Adhanom Ghebreyesus said on Monday.
However, the other arms of the trial are continuing.
Rema, discussed strange online rumors about himself in an interview with Rolling Stone. He has faced accusations of being part… Read More
A video on social media shows a surprising incident involving the US President during a press briefing. The event took… Read More
Isaac Fayose comments on the controversy surrounding singer Asake and his father. Emphasizes the importance of kindness and compassion in… Read More
A Nigerian woman is seeking an unconventional method for finding a life partner by allowing her mother to choose a… Read More
T20 Luxury, has accused food critic Opeyemi Famakin of wearing counterfeit Cartier eyewear. This accusation follows a previous incident where… Read More
Bells University of Technology expelled a first-year student for physically attacking a female student. The attack was triggered after the… Read More
This website uses cookies.